Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 512

1.

Drug-eluting non-vascular stents for localised drug targeting in obstructive gastrointestinal cancers.

Arafat M, Fouladian P, Blencowe A, Albrecht H, Song Y, Garg S.

J Control Release. 2019 Jul 4. pii: S0168-3659(19)30388-8. doi: 10.1016/j.jconrel.2019.07.001. [Epub ahead of print] Review.

PMID:
31279817
2.

A Multicenter, Randomized, Placebo-Controlled Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold.

Gelotte CK, Albrecht HH, Hynson J, Gallagher V.

J Clin Pharmacol. 2019 Jul 5. doi: 10.1002/jcph.1472. [Epub ahead of print]

PMID:
31274197
3.

Spectral Spatial Variation.

Hohmann M, Albrecht H, Mudter J, Nagulin KY, Klämpfl F, Schmidt M.

Sci Rep. 2019 May 17;9(1):7512. doi: 10.1038/s41598-019-43971-4.

4.

Discovery of CDK5 Inhibitors through Structure-Guided Approach.

Khair NZ, Lenjisa JL, Tadesse S, Kumarasiri M, Basnet SKC, Mekonnen LB, Li M, Diab S, Sykes MJ, Albrecht H, Milne R, Wang S.

ACS Med Chem Lett. 2019 Mar 20;10(5):786-791. doi: 10.1021/acsmedchemlett.9b00029. eCollection 2019 May 9.

PMID:
31098000
5.

Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial.

Stellbrink HJ, Arribas JR, Stephens JL, Albrecht H, Sax PE, Maggiolo F, Creticos C, Martorell CT, Wei X, Acosta R, Collins SE, Brainard D, Martin H.

Lancet HIV. 2019 Jun;6(6):e364-e372. doi: 10.1016/S2352-3018(19)30080-3. Epub 2019 May 5.

PMID:
31068272
6.

Laparoscopic sphincter reconstruction after abdominoperineal resection: feasibility and technical aspects.

Albrecht H, Gretschel S.

Tech Coloproctol. 2019 Apr;23(4):367-372. doi: 10.1007/s10151-019-01962-7. Epub 2019 Apr 15.

PMID:
30982933
7.

Perceived distress, personality characteristics, coping strategies and psychosocial impairments in a national German multicenter cohort of patients with Crohn's disease and ulcerative colitis.

Petruo VA, Krauss E, Kleist A, Hardt J, Hake K, Peirano J, Krause T, Ehehalt R, von Arnauld de la Perriére P, Büning J, Treml O, Krauss N, Albrecht H, Felten G, Hermannspahn U, Burkhardt U, Eisold M, Teich N, Siegmund B, Maaser C, Bokemeyer B, Baumgart DC, Neurath MF, Mudter J; German IBD Study Group (GISG) KND.

Z Gastroenterol. 2019 Apr;57(4):473-483. doi: 10.1055/a-0838-6371. Epub 2019 Apr 9.

PMID:
30965377
8.

Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates.

Ramsey EG, Royer J, Bookstaver PB, Justo JA, Kohn J, Albrecht H, Al-Hasan MN.

Int J Antimicrob Agents. 2019 Jul;54(1):1-7. doi: 10.1016/j.ijantimicag.2019.03.010. Epub 2019 Mar 15.

PMID:
30885805
9.

Real-world persistence and benefit-risk profile of fingolimod over 36 months in Germany.

Ziemssen T, Lang M, Tackenberg B, Schmidt S, Albrecht H, Klotz L, Haas J, Lassek C, Couto CA, Findlay JA, Cornelissen C; PANGAEA study group.

Neurol Neuroimmunol Neuroinflamm. 2019 Mar 7;6(3):e548. doi: 10.1212/NXI.0000000000000548. eCollection 2019 May.

10.

Investigation of random lasing as a feedback mechanism for tissue differentiation during laser surgery.

Hohmann M, Dörner D, Mehari F, Chen C, Späth M, Müller S, Albrecht H, Klämpfl F, Schmidt M.

Biomed Opt Express. 2019 Jan 23;10(2):807-816. doi: 10.1364/BOE.10.000807. eCollection 2019 Feb 1.

11.

Discovery of N-phenyl-4-(1H-pyrrol-3-yl)pyrimidin-2-amine derivatives as potent Mnk2 inhibitors: design, synthesis, SAR analysis, and evaluation of in vitro anti-leukaemic activity.

Abdelaziz AM, Diab S, Islam S, Basnet SKC, Noll B, Li P, Mekonnen LB, Lu J, Albrecht H, Milne RW, Gerber C, Yu M, Wang S.

Med Chem. 2018 Dec 18. doi: 10.2174/1573406415666181219111511. [Epub ahead of print]

PMID:
30569866
12.

Factors Influencing Staff's Attitude Toward Electroconvulsive Therapy: A Comparison of New Versus Experienced Electroconvulsive Therapy Clinics.

Scholz-Hehn AD, Müller JC, Deml R, Methfessel I, Zilles D, Hädrich F, Hecht G, Luedecke D, Gornisch J, Albrecht H, Stumm L, Freundlieb N.

J ECT. 2019 Jun;35(2):106-109. doi: 10.1097/YCT.0000000000000544.

PMID:
30308568
13.

Slow motion in films and video clips: Music influences perceived duration and emotion, autonomic physiological activation and pupillary responses.

Wöllner C, Hammerschmidt D, Albrecht H.

PLoS One. 2018 Jun 22;13(6):e0199161. doi: 10.1371/journal.pone.0199161. eCollection 2018.

14.

Cost-Effectiveness Analysis of Early vs Late Diagnosis of HIV-Infected Patients in South Carolina.

Rampaul M, Edun B, Gaskin M, Albrecht H, Weissman S.

South Med J. 2018 Jun;111(6):355-358. doi: 10.14423/SMJ.0000000000000819.

PMID:
29863227
15.

Large set data mining reveals overexpressed GPCRs in prostate and breast cancer: potential for active targeting with engineered anti-cancer nanomedicines.

Kübler E, Albrecht H.

Oncotarget. 2018 May 18;9(38):24882-24897. doi: 10.18632/oncotarget.25427. eCollection 2018 May 18.

16.

Reply to comments: duration of antimicrobial therapy for Gram-negative bacteremia secondary to urinary source of infection.

Al-Hasan MN, Nelson AN, Justo JA, Albrecht H, Kohn J, Brandon Bookstaver P.

Infection. 2018 Apr;46(2):283-284. doi: 10.1007/s15010-018-1123-7. Epub 2018 Feb 7. No abstract available.

PMID:
29417465
17.

Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles.

Zhang W, Song Y, Eldi P, Guo X, Hayball JD, Garg S, Albrecht H.

Int J Nanomedicine. 2018 Jan 9;13:293-305. doi: 10.2147/IJN.S152485. eCollection 2018.

18.

The Beta 2 Adrenergic Receptor Antagonist Timolol Improves Healing of Combined Burn and Radiation Wounds.

Albrecht H, Yang HY, Kiuru M, Maksaereekul S, Durbin-Johnson B, Wong MS, Stevenson TR, Rocke DM, Isseroff RR.

Radiat Res. 2018 Apr;189(4):441-445. doi: 10.1667/RR14884.1. Epub 2018 Jan 26.

19.

Duration of Antimicrobial Therapy for Enterobacteriaceae Bacteremia: Using Convenient End Points for Convenient Conclusions.

Al-Hasan MN, Albrecht H, Bookstaver PB, Kohn J, Justo JA.

Clin Infect Dis. 2018 Jun 1;66(12):1978-1979. doi: 10.1093/cid/ciy043. No abstract available.

PMID:
29365087
20.

Development of Institutional Guidelines for Management of Gram-Negative Bloodstream Infections: Incorporating Local Evidence.

Nimmich EB, Bookstaver PB, Kohn J, Justo JA, Hammer KL, Albrecht H, Al-Hasan MN.

Hosp Pharm. 2017 Nov;52(10):691-697. doi: 10.1177/0018578717720506. Epub 2017 Jul 21.

21.

Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit-Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA.

Ziemssen T, Lang M, Tackenberg B, Schmidt S, Albrecht H, Klotz L, Haas J, Lassek C, Medin J, Cornelissen C; PANGAEA study group.

Neurotherapeutics. 2018 Jan;15(1):190-199. doi: 10.1007/s13311-017-0595-y.

22.

Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections.

Albrecht HH, Dicpinigaitis PV, Guenin EP.

Multidiscip Respir Med. 2017 Dec 11;12:31. doi: 10.1186/s40248-017-0113-4. eCollection 2017. Review.

23.

[New aspects of symptomatic MS treatment: Part 5 - fatigue].

Henze T, Feneberg W, Flachenecker P, Seidel D, Albrecht H, Starck M, Meuth SG.

Nervenarzt. 2018 Apr;89(4):446-452. doi: 10.1007/s00115-017-0442-8. Review. German.

PMID:
29079869
24.

[New aspects of symptomatic MS treatment: Part 6 - cognitive dysfunction and rehabilitation].

Henze T, Feneberg W, Flachenecker P, Seidel D, Albrecht H, Starck M, Meuth SG.

Nervenarzt. 2018 Apr;89(4):453-459. doi: 10.1007/s00115-017-0443-7. Review. German.

PMID:
29079868
25.

[New aspects of symptomatic MS treatment: Part 4-sexual dysfunction and eye movement disorders].

Henze T, Feneberg W, Flachenecker P, Seidel D, Albrecht H, Starck M, Meuth SG.

Nervenarzt. 2018 Feb;89(2):193-197. doi: 10.1007/s00115-017-0441-9. Review. German.

PMID:
29079866
26.

[What is new in symptomatic MS treatment: Part 3-bladder dysfunction].

Henze T, Feneberg W, Flachenecker P, Seidel D, Albrecht H, Starck M, Meuth SG.

Nervenarzt. 2018 Feb;89(2):184-192. doi: 10.1007/s00115-017-0440-x. Review. German.

PMID:
29079865
27.

CDK5 in oncology: recent advances and future prospects.

Lenjisa JL, Tadesse S, Khair NZ, Kumarasiri M, Yu M, Albrecht H, Milne R, Wang S.

Future Med Chem. 2017 Oct;9(16):1939-1962. doi: 10.4155/fmc-2017-0097. Epub 2017 Oct 27. Review.

PMID:
29076761
28.

[What is new in symptomatic MS treatment: Part 1-introduction and methodical approach, ataxia and tremor].

Henze T, Feneberg W, Flachenecker P, Seidel D, Albrecht H, Starck M, Meuth SG.

Nervenarzt. 2017 Dec;88(12):1421-1427. doi: 10.1007/s00115-017-0438-4. Review. German.

PMID:
29063261
29.

[What is new in symptomatic MS treatment: Part 2-gait disorder and spasticity].

Henze T, Feneberg W, Flachenecker P, Seidel D, Albrecht H, Starck M, Meuth SG.

Nervenarzt. 2017 Dec;88(12):1428-1434. doi: 10.1007/s00115-017-0439-3. Review. German.

PMID:
29063259
30.

Microbial communities and organic biomarkers in a Proterozoic-analog sinkhole.

Hamilton TL, Welander PV, Albrecht HL, Fulton JM, Schaperdoth I, Bird LR, Summons RE, Freeman KH, Macalady JL.

Geobiology. 2017 Nov;15(6):784-797. doi: 10.1111/gbi.12252.

PMID:
29035021
31.

Combination therapy vs. monotherapy for Gram-negative bloodstream infection: matching by predicted prognosis.

Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN.

Int J Antimicrob Agents. 2018 Mar;51(3):488-492. doi: 10.1016/j.ijantimicag.2017.09.007. Epub 2017 Sep 14.

PMID:
28919195
32.

Dual Inhibition of Mnk2 and FLT3 for potential treatment of acute myeloid leukaemia.

Diab S, Abdelaziz AM, Li P, Teo T, Basnet SKC, Noll B, Rahaman MH, Lu J, Hou J, Yu M, Le BT, Albrecht H, Milne RW, Wang S.

Eur J Med Chem. 2017 Oct 20;139:762-772. doi: 10.1016/j.ejmech.2017.08.006. Epub 2017 Aug 3.

PMID:
28863357
33.
34.

Plasma concentrations of ascorbic acid in a cross section of the German population.

Hagel AF, Albrecht H, Dauth W, Hagel W, Vitali F, Ganzleben I, Schultis HW, Konturek PC, Stein J, Neurath MF, Raithel M.

J Int Med Res. 2018 Jan;46(1):168-174. doi: 10.1177/0300060517714387. Epub 2017 Jul 31.

35.

Cumulative Effect of an Antimicrobial Stewardship and Rapid Diagnostic Testing Bundle on Early Streamlining of Antimicrobial Therapy in Gram-Negative Bloodstream Infections.

Bookstaver PB, Nimmich EB, Smith TJ 3rd, Justo JA, Kohn J, Hammer KL, Troficanto C, Albrecht HA, Al-Hasan MN.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00189-17. doi: 10.1128/AAC.00189-17. Print 2017 Sep.

36.

Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections.

Nelson AN, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN.

Infection. 2017 Oct;45(5):613-620. doi: 10.1007/s15010-017-1020-5. Epub 2017 May 6.

PMID:
28478600
37.

Measurement of optical properties of pig esophagus by using a modified spectrometer set-up.

Hohmann M, Lengenfelder B, Kanawade R, Klämpfl F, Douplik A, Albrecht H.

J Biophotonics. 2018 Jan;11(1). doi: 10.1002/jbio.201600187. Epub 2017 May 2.

PMID:
28464418
38.

The impact of hospitalization on the performance of capsule endoscopy (CE).

Albrecht H, Vetter M, Dauth W, Zoicas F, Neurath MF, Hagel AF.

Dig Liver Dis. 2017 Jun;49(6):647-650. doi: 10.1016/j.dld.2017.02.010. Epub 2017 Feb 20.

PMID:
28258930
39.

The Application of Hemospray in Gastrointestinal Bleeding during Emergency Endoscopy.

Hagel AF, Albrecht H, Nägel A, Vitali F, Vetter M, Dauth C, Neurath MF, Raithel M.

Gastroenterol Res Pract. 2017;2017:3083481. doi: 10.1155/2017/3083481. Epub 2017 Jan 23.

40.

The Continuum of HIV Care in Rural Communities in the United States and Canada: What Is Known and Future Research Directions.

Schafer KR, Albrecht H, Dillingham R, Hogg RS, Jaworsky D, Kasper K, Loutfy M, MacKenzie LJ, McManus KA, Oursler KA, Rhodes SD, Samji H, Skinner S, Sun CJ, Weissman S, Ohl ME.

J Acquir Immune Defic Syndr. 2017 May 1;75(1):35-44. doi: 10.1097/QAI.0000000000001329. Review.

41.

Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract Infections.

Shah A, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02313-16. doi: 10.1128/AAC.02313-16. Print 2017 May.

42.

In Search of Novel CDK8 Inhibitors by Virtual Screening.

Kumarasiri M, Teo T, Yu M, Philip S, Basnet SK, Albrecht H, Sykes MJ, Wang P, Wang S.

J Chem Inf Model. 2017 Mar 27;57(3):413-416. doi: 10.1021/acs.jcim.6b00711. Epub 2017 Feb 16.

PMID:
28191946
43.

Highly Potent, Selective, and Orally Bioavailable 4-Thiazol-N-(pyridin-2-yl)pyrimidin-2-amine Cyclin-Dependent Kinases 4 and 6 Inhibitors as Anticancer Drug Candidates: Design, Synthesis, and Evaluation.

Tadesse S, Yu M, Mekonnen LB, Lam F, Islam S, Tomusange K, Rahaman MH, Noll B, Basnet SK, Teo T, Albrecht H, Milne R, Wang S.

J Med Chem. 2017 Mar 9;60(5):1892-1915. doi: 10.1021/acs.jmedchem.6b01670. Epub 2017 Feb 16.

44.

Clinical Risk Score for Prediction of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates.

Augustine MR, Testerman TL, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN.

Infect Control Hosp Epidemiol. 2017 Mar;38(3):266-272. doi: 10.1017/ice.2016.292. Epub 2016 Dec 19.

PMID:
27989244
45.

Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis.

Battle SE, Bookstaver PB, Justo JA, Kohn J, Albrecht H, Al-Hasan MN.

J Antimicrob Chemother. 2017 Jan;72(1):299-304. Epub 2016 Sep 28.

PMID:
27986899
46.

The South Carolina rural-urban HIV continuum of care.

Edun B, Iyer M, Albrecht H, Weissman S.

AIDS Care. 2017 Jul;29(7):817-822. doi: 10.1080/09540121.2016.1270397. Epub 2016 Dec 16.

PMID:
27984917
47.

Non-tuberculous mycobacterial bloodstream infections in patients with indwelling vascular catheters - the role of sickle cell anaemia.

Edun B, Shah A, Durkin M, Whitmire M, Williams SP, Albrecht H, Al-Hasan M, Weissman S.

Infect Dis (Lond). 2017 May;49(5):341-346. doi: 10.1080/23744235.2016.1262058. Epub 2016 Dec 2.

PMID:
27911152
48.

Farmland biodiversity and agricultural management on 237 farms in 13 European and two African regions.

Lüscher G, Ammari Y, Andriets A, Angelova S, Arndorfer M, Bailey D, Balázs K, Bogers M, Bunce RG, Choisis JP, Dennis P, Díaz M, Dyman T, Eiter S, Fjellstad W, Fraser M, Friedel JK, Garchi S, Geijzendorffer IR, Gomiero T, González-Bornay G, Guteva Y, Herzog F, Jeanneret P, Jongman RH, Kainz M, Kwikiriza N, López Díaz ML, Moreno G, Nicholas-Davies P, Nkwiine C, Opio J, Paoletti MG, Podmaniczky L, Pointereau P, Pulido F, Sarthou JP, Schneider MK, Sghaier T, Siebrecht N, Stoyanova S, Wolfrum S, Yashchenko S, Albrecht H, Báldi A, Belényesi M, Benhadi-Marin J, Blick T, Buholzer S, Centeri C, Choisis N, Cuendet G, De Lange HJ, Déjean S, Deltshev C, Díaz Cosín DJ, Dramstad W, Elek Z, Engan G, Evtushenko K, Falusi E, Finch OD, Frank T, Gavinelli F, Genoud D, Gillingham PK, Grónás V, Gutiérrez M, Häusler W, Heer X, Hübner T, Isaia M, Jerkovich G, Jesus JB, Kakudidi E, Kelemen E, Koncz N, Kovacs E, Kovács-Hostyánszki A, Last L, Ljubomirov T, Mandery K, Mayr J, Mjelde A, Muster C, Nascimbene J, Neumayer J, Ødegaard F, Ortiz Sánchez FJ, Oschatz ML, Papaja-Hülsbergen S, Paschetta M, Pavett M, Pelosi C, Penksza K, Pommeresche R, Popov V, Radchenko V, Richner N, Riedel S, Scullion J, Sommaggio D, Szalkovszki O, Szerencsits E, Trigo D, Vale J, van Kats R, Vasilev A, Whittington AE, Wilkes-Allemann J, Zanetti T.

Ecology. 2016 Jun;97(6):1625. doi: 10.1890/15-1985.1.

49.

Differential effect of prior β-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa.

Hammer KL, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN.

Diagn Microbiol Infect Dis. 2017 Jan;87(1):87-91. doi: 10.1016/j.diagmicrobio.2016.09.017. Epub 2016 Sep 24.

PMID:
27810318
50.

Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections.

Kutob LF, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN.

Int J Antimicrob Agents. 2016 Nov;48(5):498-503. doi: 10.1016/j.ijantimicag.2016.07.013. Epub 2016 Aug 20.

PMID:
27590704

Supplemental Content

Loading ...
Support Center